Hpv prevalence and cervical intraepithelial neoplasia among hiv-infected women in yunnan province, china: A pilot study

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 1, 2012, Pages 91-96

  Zhang, Hong Yun ^a   Tiggelaar, Sarah M ^b,c   Sahasrabuddhe, Vikrant V ^c   Smith, Jennifer S ^d   Jiang, Cheng Qin ^e   Mei, Run Bo ^e   Wang, Xian Guo ^e   Li, Zu An ^e   Qiao, You Lin ^b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d University of North Carolina at Chapel Hill   (United States)

^e Women and Children's Hospital of Luxi County   (China)

Author keywords

Cervical cancer; China; HIV AIDS; HPV; Prevention; Screening

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CHINA; COLPOSCOPY; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; MIXED INFECTION; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PILOT STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHINA; COINFECTION; COLPOSCOPY; DNA, VIRAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PILOT PROJECTS; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84864878884     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.1.091     Document Type: Article

References (34)

1. Akinwuntan AL, Adesina OA, Okolo CA, et al (2008). Correlation of cervical cytology and visual inspection with acetic acid in HIV-positive women. J Obstet Gynaecol, 28, 638-41.
2. Belinson JL, Qiao YL, Pretorius RG, et al (2003). Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. Int J Gynecol Cancer, 13, 819-26.
3. de Andrade AC, Luz PM, Velasque L, et al (2011). Factors associated with colposcopy-histopathology confirmed cervical intraepithelial neoplasia among HIV-infected women from Rio De Janeiro, Brazil. PLoS One, 6, e18297.
4. Denny L, Boa R, Williamson AL, et al (2008). Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. Obstet Gynecol, 111, 1380-7.
5. Dexeus S, Cararach M, Dexeus D (2002). The role of colposcopy in modern gynecology. Eur J Gynaecol Oncol, 23, 269-77.
6. Franceschi S, Jaffe H (2007). Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy. Clin Infect Dis, 45, 510-3.
7. Gakidou E, Nordhagen S, Obermeyer Z (2008). Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med, 5, e132.
8. Harrell FE, Jr., Lee KL, Matchar DB, Reichert TA (1985). Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treat Rep, 69, 1071-7.
9. Jia Y, Sun J, Fan L, et al (2008). Estimates of HIV prevalence in a highly endemic area of China: Dehong Prefecture, Yunnan Province. Int J Epidemiol, 37, 1287-96.
10. Joint United Nations Programme on HIV/AIDS and World Health Organization (2010). AIDS epidemic update.
11. Kosinski AS, Barnhart HX (2003). Accounting for nonignorable verification bias in assessment of diagnostic tests. Biometrics, 59, 163-71.
12. Lu L, Jia MH, Zhang XB, et al (2004). [Analysis for epidemic trend of acquired immunodeficiency syndrome in Yunnan Province of China]. Zhonghua Yu Fang Yi Xue Za Zhi, 38, 309-12.
13. Luchters SM, Vanden Broeck D, Chersich MF, et al (2010). Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers. BMC Infect Dis, 10, 18.
14. Massad LS, Schneider M, Watts H, et al (2001). Correlating papanicolaou smear, colposcopic impression, and biopsy: results from the women's interagency HIV study. J Low Genit Tract Dis, 5, 212-8.
15. Mwanahamuntu MH, Sahasrabuddhe VV, Stringer JS, Parham GP (2008). Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes. Bull World Health Organ, 86, D-E.
16. Nanda K, McCrory DC, Myers ER, et al (2000). Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med, 132, 810-9.
17. Palefsky JM, Holly EA (2003). Chapter 6: Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr, 31, 41-6.
18. Pan Q, Belinson JL, Li L, et al (2003). A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study. Acta Cytol, 47, 45-50.
19. Qiao YL, Sellors JW, Eder PS, et al (2008). A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol, 9, 929-36.
20. Richart RM (1973). Cervical intraepithelial neoplasia. Pathol Annu, 8, 301-28.
21. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, et al (2007). Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer, 96, 1480-3.
22. Sahasrabuddhe VV, Bhosale RA, Joshi SN, et al (2010). Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India. PLoS One, 5, e8634.
23. Sahasrabuddhe VV, Bhosale RA, Kavatkar AN, et al (2011). Comparison of visual inspection with acetic acid (VIA) and cervical cytology to detect high grade cervical neoplasia among HIV-infected women in India. Int J Cancer, 130, 234-40.
24. Shi JF, Canfell K, Lew JB, Qiao YL (2012). The burden of cervical cancer in China: Synthesis of the evidence. Int J Cancer, 130, 641-52.
25. Strickler HD, Burk RD, Fazzari M, et al (2005). Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst, 97, 577-86.
26. Terry G, Ho L, Londesborough P, et al (2001). Detection of high-risk HPV types by the hybrid capture 2 test. J Med Virol, 65, 155-62.
27. Ting J, Kruzikas DT, Smith JS (2010). A global review of age-specific and overall prevalence of cervical lesions. Int J Gynecol Cancer, 20, 1244-9.
28. Tornesello ML, Duraturo ML, Giorgi-Rossi P, et al (2008). Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women. J Gen Virol, 89, 1380-9.
29. Videla S, Darwich L, Canadas MP, et al (2009). Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology. J Acquir Immune Defic Syndr, 50, 168-75.
30. Yu ES, Xie Q, Zhang K, Lu P, Chan LL (1996). HIV infection and AIDS in China, 1985 through 1994. Am J Public Health, 86, 1116-22.
31. Zhang L, Chen Z, Cao Y, et al (2004). Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china. J Virol, 78(24), 13591-9.
32. Zhang Y, Lu L, Ba L, et al (2006). Dominance of HIV-1 subtype CRF01_AE in sexually acquired cases leads to a new epidemic in Yunnan province of China. PLoS Med, 3, e443.
33. Zheng X, Tian C, Choi KH, et al (1994). Injecting drug use and HIV infection in southwest China. AIDS, 8, 1141-7.
34. Zheng XW (1991). A preliminary study on the behavior of 225 drug abusers and the risk factors of HIV infection in Ruili county Yunnan Province. Zhonghua Liu Xing Bing Xue Za Zhi, 12, 12-4 (in Chinese)